{"title":"Non-punitive Approach in Patient Safety Program","authors":"M. Vosoughian, Shide Dabir, M. Moshari","doi":"10.5812/jcma-148653","DOIUrl":"https://doi.org/10.5812/jcma-148653","url":null,"abstract":"<jats:p/>","PeriodicalId":36599,"journal":{"name":"Journal of Cellular and Molecular Anesthesia","volume":"17 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141661263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Singaravelan Mariyappan, Anjana R, P. S, Naveena P, Sabapathy Appavoo V A, Arbind Kumar Choudhary
: This study aimed to compare the Baska mask and the endotracheal tube, two devices used to manage patient airways during laparoscopic surgery. Fifty patients undergoing laparoscopic cholecystectomy were randomly assigned to receive either the Baska mask or the endotracheal tube. Data on patients’ demographic and physical status, as well as their heart rate, blood pressure, oxygen level, and ease of device insertion, were collected. The mean BMI for the Baska mask group was 24.68 kg/m² (± 4), and for the Endotracheal tube group, it was 24.83 kg/m² (± 4.14), showing no significant difference (P = 0.9768). However, significant differences were observed in hemodynamic parameters. Patients in the endotracheal tube group exhibited higher heart rates, blood pressure, and mean arterial pressure, indicating more cardiovascular stress than those in the Baska mask group. The endotracheal tube also caused more throat irritation, with more patients reporting post-surgery sore throat. The Baska mask was found to be easier and quicker to insert, requiring less skill and time. Both devices provided adequate oxygenation, but the endotracheal tube had more negative effects on the cardiovascular system and throat. In conclusion, the Baska mask could be a better alternative for laparoscopic surgery, improving both physiological parameters and patient comfort.
{"title":"Comparison of Baska Mask Versus Endotracheal Tube for General Anesthesia in Laparoscopic Cholecystectomy: A Randomized Controlled Trial","authors":"Singaravelan Mariyappan, Anjana R, P. S, Naveena P, Sabapathy Appavoo V A, Arbind Kumar Choudhary","doi":"10.5812/jcma-145475","DOIUrl":"https://doi.org/10.5812/jcma-145475","url":null,"abstract":": This study aimed to compare the Baska mask and the endotracheal tube, two devices used to manage patient airways during laparoscopic surgery. Fifty patients undergoing laparoscopic cholecystectomy were randomly assigned to receive either the Baska mask or the endotracheal tube. Data on patients’ demographic and physical status, as well as their heart rate, blood pressure, oxygen level, and ease of device insertion, were collected. The mean BMI for the Baska mask group was 24.68 kg/m² (± 4), and for the Endotracheal tube group, it was 24.83 kg/m² (± 4.14), showing no significant difference (P = 0.9768). However, significant differences were observed in hemodynamic parameters. Patients in the endotracheal tube group exhibited higher heart rates, blood pressure, and mean arterial pressure, indicating more cardiovascular stress than those in the Baska mask group. The endotracheal tube also caused more throat irritation, with more patients reporting post-surgery sore throat. The Baska mask was found to be easier and quicker to insert, requiring less skill and time. Both devices provided adequate oxygenation, but the endotracheal tube had more negative effects on the cardiovascular system and throat. In conclusion, the Baska mask could be a better alternative for laparoscopic surgery, improving both physiological parameters and patient comfort.","PeriodicalId":36599,"journal":{"name":"Journal of Cellular and Molecular Anesthesia","volume":"8 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141362798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Context: Delirium is a common complication observed in patients undergoing open-heart surgery, leading to adverse outcomes and increased healthcare costs. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist with analgesic and neuroprotective properties, has been reported to have potential protective effects against delirium. In this scoping review, we aim to explore the existing literature on the effect of ketamine administration in open-heart surgery on the incidence of delirium. Evidence Acquisition: In the latter part of 2023, a retrospective analysis was conducted to investigate the impact of administering ketamine on delirium occurrence following coronary artery bypass surgery. Researchers utilized Medical Subject Headings (MeSH) to identify key terms and searched various databases, including Scopus, Web of Science, PubMed, and Cochrane, as well as search engines like Google Scholar, alongside Iran SID and Iran ISC databases. Following the elimination of duplicates and irrelevant studies, the review encompassed six studies from Iran, Turkey, Canada, the United States, and Thailand. Results: The search strategy yielded 1100 articles, of which 100 were excluded due to duplicates. After excluding conference papers, systematic reviews, unrelated languages, unavailable full texts, and book chapters, 87 full-text studies were reviewed. Finally, 6 studies (5 studies in English and one study in Persian) met the inclusion criteria and were analyzed. Conclusions: Recent trials have shown that the effect of ketamine administration on the incidence of delirium after coronary artery bypass graft (CABG) surgery is equivocal. While some studies suggest that ketamine may serve as a promising solution for reducing the incidence of delirium, others suggest that it may lead to adverse experiences and raise concerns about its safety. Further research in this area is necessary to optimize postoperative recovery and minimize risks. Currently, physicians must carefully evaluate the potential benefits and side effects of ketamine for each patient and be aware of the latest evidence.
{"title":"The Effect of Ketamine Administration on the Incidence of Delirium After Coronary Artery Bypass Graft Surgery: A Scoping Review","authors":"Shahnam Sedigh Maroufi, Mehrdad Mesbah Kiaei, Maryam Aligholizadeh, A. Saei, Siavash Sangi, Parisa Akbarpour","doi":"10.5812/jcma-147124","DOIUrl":"https://doi.org/10.5812/jcma-147124","url":null,"abstract":"Context: Delirium is a common complication observed in patients undergoing open-heart surgery, leading to adverse outcomes and increased healthcare costs. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist with analgesic and neuroprotective properties, has been reported to have potential protective effects against delirium. In this scoping review, we aim to explore the existing literature on the effect of ketamine administration in open-heart surgery on the incidence of delirium. Evidence Acquisition: In the latter part of 2023, a retrospective analysis was conducted to investigate the impact of administering ketamine on delirium occurrence following coronary artery bypass surgery. Researchers utilized Medical Subject Headings (MeSH) to identify key terms and searched various databases, including Scopus, Web of Science, PubMed, and Cochrane, as well as search engines like Google Scholar, alongside Iran SID and Iran ISC databases. Following the elimination of duplicates and irrelevant studies, the review encompassed six studies from Iran, Turkey, Canada, the United States, and Thailand. Results: The search strategy yielded 1100 articles, of which 100 were excluded due to duplicates. After excluding conference papers, systematic reviews, unrelated languages, unavailable full texts, and book chapters, 87 full-text studies were reviewed. Finally, 6 studies (5 studies in English and one study in Persian) met the inclusion criteria and were analyzed. Conclusions: Recent trials have shown that the effect of ketamine administration on the incidence of delirium after coronary artery bypass graft (CABG) surgery is equivocal. While some studies suggest that ketamine may serve as a promising solution for reducing the incidence of delirium, others suggest that it may lead to adverse experiences and raise concerns about its safety. Further research in this area is necessary to optimize postoperative recovery and minimize risks. Currently, physicians must carefully evaluate the potential benefits and side effects of ketamine for each patient and be aware of the latest evidence.","PeriodicalId":36599,"journal":{"name":"Journal of Cellular and Molecular Anesthesia","volume":" 39","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141368388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Smart Drug Delivery in Anesthesia: A Need or an Option?","authors":"Mastaneh Dahi Taleghani, M. Vosoughian","doi":"10.5812/jcma-146490","DOIUrl":"https://doi.org/10.5812/jcma-146490","url":null,"abstract":"<jats:p/>","PeriodicalId":36599,"journal":{"name":"Journal of Cellular and Molecular Anesthesia","volume":"189 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141368774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mahtab Poorzamani, B. Narouie, Mohammad Hamidi Madani, Mohammad Hossein Soltani, Fatemeh Roodneshin, Ekram Mortazavi, Ahmad Saeed Yaqubi
Background: Postoperative nausea and vomiting (PONV) is a common issue associated with laparoscopic procedures, prompting the exploration of various prevention methods. Objectives: This study aimed to assess the efficacy of Ginger capsules compared to Dexamethasone in preventing PONV following laparoscopic nephrectomy. Methods: A total of 131 patients undergoing laparoscopic nephrectomy were randomly assigned to receive either Ginger or Dexamethasone 30 minutes before anesthesia. Vomiting frequency in the recovery room and within the initial 24 hours post-surgery was recorded and compared between the two groups. Results: In the recovery room (within the first 6 hours post-surgery), vomiting occurred in 37% of patients in the Dexamethasone group and 11% in the Ginger group (P = 0.001). Similarly, within the first 24 hours post-operation, vomiting frequency was significantly lower in the Ginger group (19.7% vs. 47%: P = 0.001). Additionally, fewer patients in the Ginger group required intravenous medications like Ondansetron or Metoclopramide within the initial 24 hours post-surgery compared to the Dexamethasone group (8.2% vs. 38%, respectively; P = 0.001). Patients' self-reported post-surgical pain and discomfort using a Visual Analog Scale (VAS) showed no significant difference between the two groups (P = 0.45). No adverse effects were observed in either the Ginger or Dexamethasone groups. Conclusions: Ginger, administered in 500 mg oral capsules, is a safe and cost-effective option for reducing PONV incidence following laparoscopic nephrectomy.
{"title":"The Evaluation of the Effectiveness of Ginger Compared to Dexamethasone in Preventing Postoperative Nausea and Vomiting in Laparoscopic Nephrectomy","authors":"Mahtab Poorzamani, B. Narouie, Mohammad Hamidi Madani, Mohammad Hossein Soltani, Fatemeh Roodneshin, Ekram Mortazavi, Ahmad Saeed Yaqubi","doi":"10.5812/jcma-146532","DOIUrl":"https://doi.org/10.5812/jcma-146532","url":null,"abstract":"Background: Postoperative nausea and vomiting (PONV) is a common issue associated with laparoscopic procedures, prompting the exploration of various prevention methods. Objectives: This study aimed to assess the efficacy of Ginger capsules compared to Dexamethasone in preventing PONV following laparoscopic nephrectomy. Methods: A total of 131 patients undergoing laparoscopic nephrectomy were randomly assigned to receive either Ginger or Dexamethasone 30 minutes before anesthesia. Vomiting frequency in the recovery room and within the initial 24 hours post-surgery was recorded and compared between the two groups. Results: In the recovery room (within the first 6 hours post-surgery), vomiting occurred in 37% of patients in the Dexamethasone group and 11% in the Ginger group (P = 0.001). Similarly, within the first 24 hours post-operation, vomiting frequency was significantly lower in the Ginger group (19.7% vs. 47%: P = 0.001). Additionally, fewer patients in the Ginger group required intravenous medications like Ondansetron or Metoclopramide within the initial 24 hours post-surgery compared to the Dexamethasone group (8.2% vs. 38%, respectively; P = 0.001). Patients' self-reported post-surgical pain and discomfort using a Visual Analog Scale (VAS) showed no significant difference between the two groups (P = 0.45). No adverse effects were observed in either the Ginger or Dexamethasone groups. Conclusions: Ginger, administered in 500 mg oral capsules, is a safe and cost-effective option for reducing PONV incidence following laparoscopic nephrectomy.","PeriodicalId":36599,"journal":{"name":"Journal of Cellular and Molecular Anesthesia","volume":"292 1‐2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140719828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：